entertainment -WSS

entertainment

author：fashion 2025-09-06 05:03:02 - browse：66664

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： More doctors should go into startup world

entertainment

WSS

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Telehealth options flood the market as retailers push virtual care

Extreme heat events are a public health emergency

Will General Catalyst be the first of many hospital takeovers?

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Emergency medicine has repudiated 'excited delirium.' Now what?

hotspot

entertainment

hotspot

Supreme Court strikes down use of affirmative action

Diversify hospital leadership teams to protect BIPOC patient health

Supreme Court strikes down use of affirmative action

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Medical leaders decry Supreme Court decision on affirmative action

Biotech incubator Curie.Bio graduates its first startup

Medicare details structure of new drug price negotiation program

STAT Executive Editor Rick Berke on STAT's 8th birthday

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: New research from Sanofi, Regeneron, etc.

focus

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

UCSF medical school apologizes for unethical prisoner experiments

Ambulance rides for just $100? Advisers want major billing fixes

Study: New antibiotic targets gonorrhea as well as last existing drug

First Opinion Podcast: How to protect health care in times of war

The new shift in health care is toward less care

entertainment

leisure time

leisure time

hotspot